Open AccessClinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistantStreptococcus pneumoniae: analysis of Phase 3 clinical trial data—authors' response: Figure 1.
Author(s) -
George G. Zhanel,
Kevin D. Wolter,
James A. Karlowsky
Publication year - 2015
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkv234
Subject(s) - azithromycin , streptococcus pneumoniae , medicine , respiratory tract infections , clinical trial , respiratory system , antibiotics , microbiology and biotechnology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom